Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2732-2740

  Salzberg, Samuel ^a   Hyman, Tehila ^a   Turm, Hagit ^a   Kinar, Yosefa ^a   Schwartz, Yaacov ^a   Nir, Uri ^a   Lejbkowicz, Flavio ^b   Huberman, Eliezer ^c  

^a BAR ILAN UNIVERSITY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; NITROBLUE TETRAZOLIUM; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOBLASTOMA PROTEIN; RNA; ZINC CHLORIDE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME KINETICS; EXPRESSION VECTOR; GROWTH REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

2',5'-OLIGOADENYLATE SYNTHETASE; CELL DIFFERENTIATION; CELL DIVISION; CHLORIDES; DIMETHYL SULFOXIDE; GRANULOCYTES; HL-60 CELLS; HUMANS; INTERFERON-BETA; LEUKEMIA, MYELOID; MACROPHAGES; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; ZINC COMPOUNDS;

EID: 0030848194     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Novick, D., Cohen, B., and Rubinstein, M. The human interferon α/β receptor: characterization and molecular cloning. Cell, 77: 391-400, 1994.
2. Uze, G., Lutfalla, G., and Gresser, I. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell, 60: 225-234, 1990.
3. Ihle, J. N. STATs. Signal transducers and activators of transcription. Cell, 84: 331-334, 1996.
4. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., and Silvennoinen, O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci., 19: 222-227, 1994.
5. Darnell, J. E., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
6. Uddin, S., Chaundin, A., and Platanias, L. C. Interaction of the transcriptional activator stat-2 with the type I interferon receptor. J. Biol. Chem., 270: 24627-24630, 1995.
7. Fu, X-Y. A transcription factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s). Cell, 70: 323-335, 1987.
8. Gutch, M. J., Daly, C., and Reich, N. C. Tyrosine phosphorylation is required for activation of an α interferon-stimulated transcription factor. Proc. Natl. Acad. Sci. USA, 89: 11411-11415, 1992.
9. Winston, L. A., and Hunter, T. JAKs, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem., 270: 30837-30840, 1995.
10. Chebath, J., Benech, P., Hovanessian, A. G., Galabru, J., and Revel, M. Four different forms of interferon-induced 2′-5′-oligo (A) synthetase identified by immunoblotting in human cells. J. Biol. Chem., 262: 3852-3857, 1987.
11. Marie, I., and Hovanessian, A. G. The 69 kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J. Biol. Chem., 267: 9933-9939, 1992.
12. Rutherford, M. N., Kumar, A., Nissim, A., Chebath, J., and Williams, B. R. The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucleic Acids Res., 19: 1917-1924, 1991.
13. Chebath, J., and Revel, M. The 2-5A system: 2-5A synthetases, isospecies and functions. In: S. Baron, D. H. Coppenhaver, F. Dianzani, R. Fleischmann, T. K. Hughes, G. R. Klimpel, D. W. Niesel, G. J. Stanton, and S. K. Tyring (eds.), Interferon, Principles and Medical Applications, pp. 225-236. Galveston, TX: The University of Texas Medical Branch at Galveston, 1992.
14. Hovanessian, A. G. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′,5′-oligoadenylate synthetase. J. Interferon Res., 11: 199-205, 1991.
15. Zhou, A., Hassel, B. A., and Silverman, R. H. Expression cloning of 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell, 72: 753-765, 1993.
16. Carroll, S. S., Chen, E., Viscount, T., Guib, J., Gehman, J., and Kuo, L. C. Cleavage of oligoribonucleotides by the 2′,5′-oligoadenylate ribonuclease L. J. Biol. Chem., 271: 4988-4992, 1996.
17. Floyd-Smith, G., Slattery, E., and Lengyel, P. Interferon action: RNA cleavage pattern of a (2′-5′) olisoadenylate-dependent endonuclease. Science (Washington DC), 212: 1020-1032, 1981.
18. n A-dependent ribonuclease. Nature (Lond.), 289: 414-417, 1981.
19. Bakhanashvili, M., Wreschner, D. H., and Salzberg, S. Specific anti-growth effect of interferon on mouse cells transformed by murine sarcoma virus. Cancer Res., 43: 1289-1294, 1983.
20. David, S., Nissim, A., Chebath, J., and Salzberg, S. 2-5A synthetase gene expression in normal and murine sarcoma virus-transformed NIH/3T3 cells. J. Virol., 63: 1116-1122, 1989.
21. Kumar, A., and Mendelsohn, J. Role of 2′-5′-oligoadenylate synthetase in γ-interferon-mediated growth inhibition of A431 cells. Cancer Res., 49: 5180-5184, 1989.
22. Birenbaum, M., Trink, B., Shainberg, A., and Salzberg, S. Activation of the Interferon system during myogenesis in vitro. Differentiation, 45: 138-145, 1990.
23. Kimchi, A. Increased levels of interferon-induced (2′-5′)oligoadenylate synthetase in mature T-lymphocytes and in differentiated Friend erythroleukemic cells. J. Interferon Res., 1: 559-569, 1981.
24. Maor, G., Salzberg, S., and Silbermann, M. The activity of 2,5-oligoadenylate synthetase, an interferon-induced enzyme, is coupled to the differentiation state of mouse condylar cartilage. Differentiation, 44: 18-24, 1990.
25. Salzberg, S., Heller, A., Zou, J-P., Collart, F. R., and Huberman, E. Interferon-independent activation of (2′-5′) oligoadenylate synthetase in Friend erythroleukemia cell variants exposed to HMBA. J. Cell Sci., 109: 1517-1526, 1996.
26. Salzberg, S., Mandelbaum, M., Zalcberg, M., and Shainberg, A. Interruption of myogenesis by transforming growth factor β1 or EGTA inhibits expression and activity of the myogenic-associated (2′-5′)oligoadenylate synthetase and PKR. Exp. Cell Res., 219: 223-232, 1995.
27. gR cells during growth inhibition. Proc. Natl. Acad. Sci. USA, 80: 4954-4958, 1983.
28. n A-dependent RNase in NIH/3T3, clone 1 cells by growth arrest and Interferon treatment. J. Biol. Chem., 260: 9501-9507, 1985.
29. Rysiecki, G., Gewert, D. R., and Williams, B. R. G. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res., 4: 649-657, 1989.
30. Yaffe, A., Schwarz, Y., Hacohen, D., Kinar, Y., Nir, U., and Salzberg, S. Inhibition of 2-5A synthetase expression by antisense RNA interferes with interferon-mediated antiviral and antiproliferative effects and induces anchorage-independent cell growth. Cell Growth & Differ., 7: 969-978, 1996.
31. Hassel, B. A., Zhou, A., Sotomayor, C., Maran, A., and Silverman, R. H. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of Interferon. EMBO J., 12: 3297-3304, 1993.
32. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., and Gallo, R. C. Terminal differentiation of human promyelocyte leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA, 75: 2458-2462, 1978.
33. Breitman, T. R., Solonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
34. 3 and phorbol 12-myristate 13-acetate. Cancer Res., 43: 4989-4996, 1983.
35. Shima, H., Nakayasu, M., Aonuma, S., Sugimura, T., and Nagao, M. Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitor of poly(ADP-ribose) polymerase or with dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA, 86: 7442-7445, 1989.
36. Homma, Y., Hennig-Chubb, C. B., and Huberman, E. Translocation of protein kinase C in human leukemia cells susceptible or resistant to differentiation induced by phorbol 12-myristate 13-acetate. Proc. Natl. Acad. Sci. USA, 83: 7316-7319, 1986.
37. Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., and Rutter, W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell, 45: 721-732, 1986.
38. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, p. 7.52. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
39. Schwartz, E. L., and Nilson, L. A. Activation of 2′,5′-oligoadenylate synthetase activity on induction of HL-60 leukemia cell differentiation. Mol. Cell. Biol., 9: 3897-3903, 1989.
40. Amati, B., and Land, H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev., 4: 102-108, 1994.
41. Hinds, P. W. The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dev., 5: 79-83, 1995.
42. Dani, C-H., Mechti, N., Piechaczyk, M., Lebleu, B., Jeanteur, D. H., and Blanchard, J. M. Increase rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA, 82: 4896-4899, 1985.
43. Jonak, G. J., and Knight, E., Jr. Selective reduction of c-myc mRNA in Daudi cells by human β-interferon. Proc. Natl. Acad. Sci. USA, 81: 1747-1750, 1984.
44. 1 cell cycle arrest but not other inhibitory responses of M1 myeloblastic cells. Cell Growth & Differ., 2: 33-41, 1991.
45. Resnitzky, D., Tiefenbrun, N., Berissi, H., and Kimchi, A. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA, 89: 402-406, 1992.
46. Tonetti, D. A., Horio, M., Collart, F. R., and Huberman, E. Protein kinase C β gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation. Cell Growth & Differ., 3: 739-745, 1992.
47. Tonetti, D. A., Henning-Chubb, C., Yamanishi, D. T., and Huberman, E. Protein kinase C β is required for macrophage differentiation of human HL-60 leukemia cells. J. Biol. Chem., 269: 23230-23235, 1994.
48. Faltynek, C. R., Princler, G. L., Gucella, G. L., Varesio, L., and Radzioch, D. A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-α A in Daudi cells. J. Biol. Chem., 264: 14305-14311, 1989.
49. James, R. I., Menoya, J., Hudson, K., Devalia, V., Ryver, J., Evans, F. J., Thomas, S., and Clemens, M. J. Role of protein kinase C in induction of gene expression and inhibition of cell proliferation by Interferon α. Eur. J. Biochem., 209: 813-822, 1992.
50. 2 domains define the specificity of STAT factor activation. J. Biol. Chem., 271: 12991-13007, 1996.
51. Wu, Y. Y., and Bradshaw, R. A. Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant pc12 cell (E2) line. J. Biol. Chem., 271: 13023-13032, 1996.
52. Yang, C. H., Shi, W., Basu, L., Murti, A., Constantinescu, S. N., Blatt, L., Croze, E., Mullersman, J. E., and Pfeffer, L. M. Direct association of STAT3 with the IFNAR-1 chain of the human type I Interferon receptor. J. Biol. Chem., 271: 8057-8061, 1996.
53. Tiefenbrun, N., and Kimchi, A. The involvement of protein kinase C in mediating growth suppressive signals of interferons in hematopoietic cells. Oncogene, 6: 1001-1007, 1991.
54. Ferbus, D., Testa, M., Titeux, M., Louache, F., and Thang, H. N. Induction of (2′-5′) oligoadenylate synthetase activity during granulocyte and monocyte differentiation. Mol. Cell. Biochem., 67: 125-133, 1985.
55. Resnitzky, D., Yarden, A., Zipori, D., and Kimchi, A. Autocrin β-related Interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell, 46: 31-40, 1986.
56. Siebenlist, U., Bressler, P., and Kelly, K. Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells. Mol. Cell. Biol., 8: 867-874, 1988.
57. Wang, J. Y. J., Knudson, E. S., and Welch, P. J. The retinoblastoma tumor suppressor protein. Adv. Cancer Res., 64: 25-85, 1994.
58. Ishida, S., Shudo, K., Takada, S., and Koike, K. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells. Cell Growth & Differ., 6: 229-237, 1995.
59. 0-like arrest. Mol. Cell. Biol., 16: 3934-3944, 1996.
60. Ihle, J. N. Cytokine receptor signalling. Nature (Lond.), 377: 591-595, 1995.
61. Ihle, J. N., and Kerr, I. M. Jak and Stats in signalling by the cytokine receptor superfamily. Trends Genet., 11: 69-74, 1995.
62. 1A cells. J. Biol. Chem., 270: 19059-19065, 1995.
63. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiachi, N., Kitaoka, T., Fukada, T., Hibi, M., and Hirano, T. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J., 15: 3651-3658, 1996.
64. Stephens, J. M., Morrison, R. F., and Pilch, P. F. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem., 271: 10441-10444, 1996.
65. Tilbrook, P. A., Bittorf, T., Calens, B. A., Busfield, S. J., Ingley, E., and Klinken, S. P. Regulation of the erythropoietin receptor and involvement of Jak2 in differentiation of J2E erythroid cells. Cell Growth & Differ., 7: 511-520, 1996.